ginsenoside rh2 has been researched along with Neoplasm Metastasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, N; Guo, W; Huo, X; Luo, J; Zhang, S; Zhang, Z | 1 |
| Maeda, M; Ota, T; Tatsuka, M | 1 |
2 other study(ies) available for ginsenoside rh2 and Neoplasm Metastasis
| Article | Year |
|---|---|
Ginsenoside Rh2 inhibits metastasis of glioblastoma multiforme through Akt-regulated MMP13.
Topics: Adult; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Ginsenosides; Glioblastoma; Humans; Male; Matrix Metalloproteinase 13; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Wound Healing | 2015 |
Anticarcinogenic effect and enhancement of metastatic potential of BALB/c 3T3 cells by ginsenoside Rh(2).
Topics: 3T3 Cells; Animals; Anticarcinogenic Agents; Apoptosis; CDC2-CDC28 Kinases; Cell Division; Cell Line, Transformed; Cell Transformation, Neoplastic; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Ginsenosides; Methylcholanthrene; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Oncogene Protein pp60(v-src); Protein Serine-Threonine Kinases; Saponins; Tumor Cells, Cultured | 2001 |